Anthem Biosciences Ltd

ANTHEM

Company Profile

  • Business description

    Anthem Biosciences Ltd is mainly engaged in discovering, developing, manufacturing, and commercializing biopharmaceutical products that address unmet needs and provide biological solutions to improve industrial performance in all areas. The company offers its CRDMO services to biotech, pharmaceutical, and other companies for the development of large and small drug molecules, and also runs a products business offering specialty ingredients like fermentation products, peptides, lipids, probiotics, APIs, biosimilars, etc. Its reportable segments are: Contract Research Development and Manufacturing Services (CRDMO), which derives maximum revenue, and Specialty Ingredients. Geographically, the company generates maximum revenue from Europe, followed by North America, India, and other regions.

  • Contact

    Phase 1, Canara Bank Road
    No. 49, F1 and F2, Bommasandra Industrial Area
    Bommasandra
    BangaloreKA560099
    IND

    T: +91 8066724000

    https://www.anthembio.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 March 2027

    Employees

    3,302

Stocks News & Analysis

stocks

Pure-play data center share raises capital to fund AI demand

Funding the next wave of data center growth.
stocks

Chart of the Week: BHP’s growth story faces a reality check

China’s slowing economy could weigh on BHP’s future growth.
stocks

3 best ASX growth stocks to buy for the long term

Here’s three high-quality growth companies with wide moats.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,978.8034.20-0.38%
CAC 408,338.8139.05-0.47%
DAX 4024,830.9884.51-0.34%
Dow JONES (US)52,146.42406.55-0.77%
FTSE 10010,600.3728.130.27%
HKSE24,562.24446.36-1.78%
NASDAQ25,520.24361.70-1.40%
Nikkei 22564,141.122,694.42-4.03%
NZX 50 Index13,694.6879.900.59%
S&P 5007,457.6976.08-1.01%
S&P/ASX 2008,796.7020.10-0.23%
SSE Composite Index3,764.15118.26-3.05%

Market Movers